Hypertrophic cardiomyopathy: an important cause of sudden death.

W J McKenna, J E Deanfield

Retrospective analysis was performed to assess the natural history in relation to clinical and haemodynamic features in 37 patients in whom hypertrophic cardiomyopathy had been diagnosed in childhood. At diagnosis they were aged 1 to 14 years (mean 9 years). Eighteen presented with chest pain and either dyspnoea or symptoms of impaired consciousness or both; 19 were asymptomatic and were referred for evaluation of abnormalities detected during physical examination. During a mean follow up of nine years, 18 patients died, a cumulative annual medical mortality of 4.8%. Five patients experienced severe dyspnoea or chest pain: two of these had progressive dyspnoea and died in cardiac failure, and three died after myectomy. The 19 survivors were compared with the 11 sudden deaths. Eleven of the survivors and five of the sudden deaths were asymptomatic. Of 18 clinical, electrocardiographic, and haemodynamic features only syncope and electrocardiographic evidence of right ventricular hypertrophy were associated with sudden death. In children with hypertrophic cardiomyopathy sudden death was common and was not well predicted by clinical, electrocardiographic, or haemodynamic findings. Hypertrophic cardiomyopathy indicates a poor prognosis even if symptoms are absent or mild.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• McLeod, C. J., Ommen, S. R., Ackerman, M. J., Weivoda, P. L., Shen, W. K., Dearani, J. A., Schaff, H. V., Tajik, A. J., Gersh, B. J. (2007). Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J 28: 2583-2588 [Abstract] [Full Text]  
• Behr, E R, Casey, A, Sheppard, M, Wright, M, Bowker, T J, Davies, M J, McKenna, W J, Wood, D A (2007). Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death. Heart 93: 601-605 [Abstract] [Full Text]  
• Colan, S. D., Lipshultz, S. E., Lowe, A. M., Sleeper, L. A., Messere, J., Cox, G. F., Lurie, P. R., Orav, E. J., Towbin, J. A. (2007). Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry. Circulation 115: 773-781 [Abstract] [Full Text]  
• Pedrote, A., Morales, F. J., Garcia-Riesco, L., Errazquin, F. (2006). Documented exercise-induced cardiac arrest in a paediatric patient with hypertrophic cardiomyopathy. Europace 8: 430-433 [Abstract] [Full Text]  
• Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., Maron, B. J. (2005). Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 45: 697-704 [Abstract] [Full Text]  
• Maron, B. J., Casey, S. A., Hauser, R. G., Aeppli, D. M. (2003). Clinical course of hypertrophiccardiomyopathy with survival to advanced age. J Am Coll Cardiol 42: 882-888 [Abstract] [Full Text]  
• Maron, B. J. (2002). Hypertrophic Cardiomyopathy: A Systematic Review. JAMA 287: 1308-1320 [Abstract] [Full Text]  
• McKenna, W.J., Sharma, S., Elliott, P.M. (2001). Management strategies in hypertrophic cardiomyopathy: influence of age and morphology. Eur Heart J Suppl 3: L10-L14 [Abstract]  
• Janse, M.J., De Bakker, J.M.T. (2001). Arrhythmia substrate and management in hypertrophic cardiomyopathy: from molecules to implantable card ioverter-defibrillators. Eur Heart J Suppl 3: L15-L20 [Abstract]  
• Priori, S.G., Aliot, E., Blomstrom-Lundqvist, C., Bossaert, L., Breithardt, G., Brugada, P., Camm, A.J., Cappato, R., Cobbe, S.M., Di Mario, C., Maron, B.J., McKenna, W.J., Pedersen, A.K., Ravens, U., Schwartz, P.J., Trusz-Gluza, M., Vardas, P., Wellens, H.J.J., Zipes, D.P. (2001). Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22: 1374-1450  
• Maron, B.J. (2000). Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator. Eur Heart J 21: 1979-1983  
• Elliott, P. M., Poloniecki, J., Dickie, S., Sharma, S., Monserrat, L., Varnava, A., Mahon, N. G., McKenna, W. J. (2000). Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36: 2212-2218 [Abstract] [Full Text]  
• Maron, B. J., Olivotto, I., Spirito, P., Casey, S. A., Bellone, P., Gohman, T. E., Graham, K. J., Burton, D. A., Cecchi, F. (2000). Epidemiology of Hypertrophic Cardiomyopathy-Related Death : Revisited in a Large Non-Referral-Based Patient Population. Circulation 102: 858-864 [Abstract] [Full Text]  
• Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., Estes, N.A. M., Spirito, P., Casey, S. A., Stanton, M. S., Betocchi, S. (2000). Efficacy of Implantable Cardioverter-Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy. NEJM 342: 365-373 [Abstract] [Full Text]  
• Ostman-Smith, I., Wettrell, G.o., Riesenfeld, T. (1999). A cohort study of childhood hypertrophic cardiomyopathy: Improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 34: 1813-1822 [Abstract] [Full Text]  
• Maron, B. J., Mathenge, R., Casey, S. A., Poliac, L. C., Longe, T. F. (1999). Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities. J Am Coll Cardiol 33: 1590-1595 [Abstract] [Full Text]  
• Maron, B. J., Casey, S. A., Poliac, L. C., Gohman, T. E., Almquist, A. K., Aeppli, D. M. (1999). Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States Cohort. JAMA 281: 650-655 [Abstract] [Full Text]  
• Takagi, E., Yamakado, T., Nakano, T. (1999). Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 33: 206-211 [Abstract] [Full Text]  
• Yetman, A. T., Hamilton, R. M., Benson, L. N., McCrindle, B. W. (1998). Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol 32: 1943-1950 [Abstract] [Full Text]  
• Yetman, A. T., McCrindle, B. W., MacDonald, C., Freedom, R. M., Gow, R. (1998). Myocardial Bridging in Children with Hypertrophic Cardiomyopathy -- A Risk Factor for Sudden Death. NEJM 339: 1201-1209 [Abstract] [Full Text]  
• Cecchi, F, Olivotto, I, Montereggi, A, Squillatini, G, Dolara, A, Maron, B J (1998). Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Heart 79: 331-336 [Abstract] [Full Text]  
• Sadoul, N., Prasad, K., Elliott, P. M., Bannerjee, S., Frenneaux, M. P., McKenna, W. J. (1997). Prospective Prognostic Assessment of Blood Pressure Response During Exercise in Patients With Hypertrophic Cardiomyopathy. Circulation 96: 2987-2991 [Abstract] [Full Text]  
• Schwartz, M. L., Cox, G. F., Lin, A. E., Korson, M. S., Perez-Atayde, A., Lacro, R. V., Lipshultz, S. E. (1996). Clinical Approach to Genetic Cardiomyopathy in Children. Circulation 94: 2021-2038 [Abstract] [Full Text]  
• Wigle, E. D., Rakowski, H., Kimball, B. P., Williams, W. G. (1995). Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment. Circulation 92: 1680-1692 [Full Text]  
• Saumarez, R. C., Slade, A. K. B., Grace, A. A., Sadoul, N., Camm, A. J., McKenna, W. J. (1995). The Significance of Paced Electrogram Fractionation in Hypertrophic Cardiomyopathy : A Prospective Study. Circulation 91: 2762-2768 [Abstract] [Full Text]